BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9045932)

  • 1. Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: requirement for all three p70 immunoglobulin domains.
    Rojo S; Wagtmann N; Long EO
    Eur J Immunol; 1997 Feb; 27(2):568-71. PubMed ID: 9045932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors.
    Kim J; Chwae YJ; Kim MY; Choi IH; Park JH; Kim SJ
    J Immunol; 1997 Oct; 159(8):3875-82. PubMed ID: 9378975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
    Winter CC; Gumperz JE; Parham P; Long EO; Wagtmann N
    J Immunol; 1998 Jul; 161(2):571-7. PubMed ID: 9670929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells.
    Rajagopalan S; Winter CC; Wagtmann N; Long EO
    J Immunol; 1995 Nov; 155(9):4143-6. PubMed ID: 7594568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.
    Pende D; Biassoni R; Cantoni C; Verdiani S; Falco M; di Donato C; Accame L; Bottino C; Moretta A; Moretta L
    J Exp Med; 1996 Aug; 184(2):505-18. PubMed ID: 8760804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cells.
    Rajagopalan S; Long EO
    J Immunol; 1998 Aug; 161(3):1299-305. PubMed ID: 9686591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors.
    Fan QR; Mosyak L; Winter CC; Wagtmann N; Long EO; Wiley DC
    Nature; 1997 Sep; 389(6646):96-100. PubMed ID: 9288975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human natural killer cell inhibitory receptors bind to HLA class I molecules.
    Döhring C; Colonna M
    Eur J Immunol; 1996 Feb; 26(2):365-9. PubMed ID: 8617305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation.
    Bottino C; Sivori S; Vitale M; Cantoni C; Falco M; Pende D; Morelli L; Augugliaro R; Semenzato G; Biassoni R; Moretta L; Moretta A
    Eur J Immunol; 1996 Aug; 26(8):1816-24. PubMed ID: 8765026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes.
    Winter CC; Long EO
    J Immunol; 1997 May; 158(9):4026-8. PubMed ID: 9126959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killer cell inhibitory receptor interactions with HLA class I molecules: implications for alloreactivity and transplantation.
    Young NT; Bunce M; Morris PJ; Welsh KI
    Hum Immunol; 1997 Jan; 52(1):1-11. PubMed ID: 9021404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705.
    Peruzzi M; Wagtmann N; Long EO
    J Exp Med; 1996 Oct; 184(4):1585-90. PubMed ID: 8879234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
    Kurago ZB; Lutz CT; Smith KD; Colonna M
    J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A disulfide-linked natural killer cell receptor dimer has higher affinity for HLA-C than wild-type monomer.
    Fan QR; Long EO; Wiley DC
    Eur J Immunol; 2000 Sep; 30(9):2692-7. PubMed ID: 11009104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.